3036 — Alconix Balance Sheet
0.000.00%
- ¥65bn
- ¥99bn
- ¥197bn
- 82
- 78
- 89
- 98
Annual balance sheet for Alconix, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 27,048 | 26,689 | 26,993 | 21,471 | 18,762 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 49,112 | 58,773 | 61,679 | 56,155 | 62,404 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 106,604 | 135,119 | 144,212 | 132,549 | 144,374 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 22,845 | 25,061 | 31,993 | 31,737 | 37,374 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 147,917 | 176,437 | 191,890 | 182,890 | 196,634 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 78,011 | 94,643 | 100,348 | 89,693 | 103,196 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 105,065 | 119,568 | 129,366 | 117,141 | 126,932 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 42,852 | 56,869 | 62,524 | 65,749 | 69,702 |
| Total Liabilities & Shareholders' Equity | 147,917 | 176,437 | 191,890 | 182,890 | 196,634 |
| Total Common Shares Outstanding |